Abstract:Abstract Background Diabetic nephropathy is closely related to immune-regulation, in which macrophages play a crucial role. In diabetic nephropathy, the classically activated macrophages (M1) increased while the alternatively activated macrophages (M2) decreased in kidney. Mesenchymal stem cells (MSCs) administration can alleviate diabetic nephropathy, however, the mechanisms still remain unclear. MSCs have been shown to stimulate macrophages from a M1 phenotype to a M2 phenotype. Thus, we aimed to investigate whether the polarization of M1/M2 induced by MSCs was involved in diabetic nephropathy (DN). Methods In our study, we injected human umbilical cord mesenchymal stem cells (UC-MSCs) into type 2 diabetic nephropathy rats induced by high fat diet combined with a low dose of streptozotocin. To clarify the effect of MSCs on macrophages polarization, peritoneal macrophages were extracted and directed into M1 macrophages by lipopolysaccharides (LPS) in vitro. Then we co-cultured UC-MSCs with M1 macrophages, and evaluated the effect on differentiation. We also co-cultured rat glomerular mesangial cells (HBZY-1) in high-glucose DMEM with LPS-stimulated macrophages (M1 macrophages) or UC-MSCs-induced M2 macrophages in a trans-well system to clarify the complex mechanisms by which UC-MSCs-induced M2 macrophages improve the progression of DN. Results The UC-MSCs infusion reduced the infiltration of M1 macrophages, and increased the infiltration of M2 macrophages in the glomerulus, thereby attenuating histopathological renal damage and improving renal inflammation and fibrosis in diabetic nephropathy rats. After coculturing UC-MSCs with M1 macrophages, we found that the M1 macrophage maker inducible nitric oxide synthase (NOS2) and the mRNA and protein levels of the related pro-inflammatory cytokines TNF-α, TGF-β and IL-1β decreased. However, the expression of the M2 macrophage markers CD163 and CD206, as well as the anti-inflammatory cytokine IL-10 increased observably. Furthermore, UC-MSCs increased the expression of IL-4Rα on macrophages by secreting IL-6; blocking IL-6 secretion inhibited the UC-MSCs effect on M2 macrophage polarization. Then we explored the mechanism by which M2 macrophages ameliorate diabetic nephropathy in vitro and found that UC-MSCs-induced M2 macrophages attenuated the secretion of the chemokine monocyte chemoattractant protein-1(MCP-1) in hyperglycemia-induced mesangial cells, which led to reduce macrophage recruitment and infiltration. Moreover, UC-MSCs-induced M2 macrophages inhibited TGF-β in glomerular mesangial cells, thereby reducing the synthesis of collagen I and collagen IV. Conclusions Our study proposes and discusses a mechanism by which MSCs promote the polarization of macrophages from M1 into M2 in the kidney, thereby ameliorating diabetic nephropathy.

Exosomes derived from umbilical cord-derived mesenchymal stem cells exposed to diabetic microenvironment enhance M2 macrophage polarization and protect against diabetic nephropathy

Human umbilical cord mesenchymal stem cell-derived exosomes mitigate diabetic nephropathy via enhancing M2 macrophages polarization

MicroRNA-146a-5p-modified human umbilical cord mesenchymal stem cells enhance protection against diabetic nephropathy in rats through facilitating M2 macrophage polarization

Mesenchymal stem cells polarize macrophages to an anti-inflammatory phenotype to ameliorate diabetic nephropathy

MicroRNA-146a-5p-modified Human Umbilical Cord Mesenchymal Stem Cells Enhance Protection Against Renal Injury in Diabetic Nephropathy Through Facilitating M2 Macrophage Polarization by Targeting TRAF6

Mesenchymal Stem Cells Elicit Macrophages into M2 Phenotype Via Improving Transcription Factor EB-mediated Autophagy to Alleviate Diabetic Nephropathy

Mesenchymal stem cell-derived exosomes ameliorate diabetic kidney disease through NOD2 signaling pathway

Exendin-4-enriched exosomes from hUCMSCs alleviate diabetic nephropathy via gut microbiota and immune modulation

Mesenchymal Stem Cell-Derived Exosomes Carry MicroRNA-125a to Protect Against Diabetic Nephropathy by Targeting Histone Deacetylase 1 and Downregulating Endothelin-1

Exosome secreted from adipose-derived stem cells attenuates diabetic nephropathy by promoting autophagy flux and inhibiting apoptosis in podocyte

Human umbilical cord mesenchymal stem cell-derived exosomes ameliorate renal fibrosis in diabetic nephropathy by targeting Hedgehog/SMO signaling

Renal Tissue-Derived Exosomal miRNA-34a in Diabetic Nephropathy Induces Renal Tubular Cell Fibrosis by Promoting the Polarization of M1 Macrophages

The bone mesenchymal stem cell-derived exosomal miR-146a-5p promotes diabetic wound healing in mice via macrophage M1/M2 polarization

Diabetic microenvironment preconditioning of adipose tissue-derived mesenchymal stem cells enhances their anti-diabetic, anti-long-term complications, and anti-inflammatory effects in type 2 diabetic rats

Human umbilical cord-derived mesenchymal stem cells direct macrophage polarization to alleviate pancreatic islets dysfunction in type 2 diabetic mice

Mitochondrial Transfer from Mesenchymal Stem Cells to Macrophages Restricts Inflammation and Alleviates Kidney Injury in Diabetic Nephropathy Mice Via PGC-1α Activation

Bone Marrow Mesenchymal Stem Cell-Derived Exosomes Alleviate Diabetic Kidney Disease in Rats by Inhibiting Apoptosis and Inflammation

Early Intervention with Mesenchymal Stem Cells Prevents Nephropathy in Diabetic Rats by Ameliorating the Inflammatory Microenvironment

Exosomes Derived from Diabetic Microenvironment-Preconditioned Mesenchymal Stem Cells Ameliorate Nonalcoholic Fatty Liver Disease and Inhibit Pyroptosis of Hepatocytes

ERK Modulates Macrophage Polarization and Alters Exosome miRNA Expression in Diabetic Nephropathy.

Human Umbilical Cord-Derived Mesenchymal Stem Cells Prevent the Progression of Early Diabetic Nephropathy Through Inhibiting Inflammation and Fibrosis